Introduction
Cytidine diphosphate choline (CDP-choline) is a drug known to have facilitatory effects on consciousness and on motor activity mediated by the Pyramidal system when administered by intravenous route as demonstrated in our previous studies1-4) . It was described in the preceding paper5) that orally administered CDP-choline produced no such effects as investigated with respect to arousal response and evoked muscular discharge2) . However, such experiments with these Parameters are acute tests whereas chronic experiments simulant of clinical conditions were thought to be necessary to estimate whether the oral administration of the compound might be effective or ineffective when applied clinically.
In view of this, we investigated the influence of orally administered CDP-choline on the threshold of evoked muscular discharge by stimulation of the cerebral cortex in rabbits.
Methods
Unanesthetized albino rabbits were used in all experiments. The animal was restrained on a stereotaxic instrument (Todai Noken type), and electrodes were implanted in the cerebral cortex to be used as chronic stimulating electrodes. -Additional electrodes were inserted bilaterally in the internal capsule for its destruction. Namely, the animal was sheared extensively over the parietal region of the scalp. After shaving and disinfection of the scalp, the skull was exposed through the sagittal incision along the median line. The periosteum was then sufficiently detached with a bone curette, and the head rerestrained in a position as to maintain the bregma 1. 5 mm higher than the level of the lambda adjusting its position exactly to the stereotaxic coordinates of Sawyer et al. 9) Subsequently, points for insertion of electrodes to destroy the internal capsule, calculated according to the stereotaxic coordinates, were marked on the surface of the skull. For insertion of electrodes in the cerebral cortex, points slightly posterior to the coronal suture and 2 mm external from the sagittal suture were marked. Then holes, about 1 mm in diameter, were made at these points in the skull using a dental drill, followed by insertion of electrodes into the brain by means of electrode supports. The electrodes used Supplement to J. Kansai Med. Univ. , Vol. 34, Dec. 1982 S -14 were bipolar side-by-side needle electrodes, each consisting of two, paint-insulated stainless wires, 250 u in diam. , arranged in parallel, deinsulated 0. 5 mm from the tip and bound together with the same paint, the tips being slid about 1 mm apart. Chronic electrodes were implanted into the calculated depth from the surface of the skull to the specified intracerebral region, and the exposed parts protected by encasing with vinyl tubes, followed by fixation on to the skull using dental cement. Besides proper cleansing and disinfection of the surgical field and instruments, the animal was given an intramuscular dose of 1, 000, 000 units of penicillin after the operation.
Evoked muscular discharges were led off from the flexor muscle of the fore-limb (M. articuloulnaris) and from the extensor muscle of the hind-limb (M. quadriceps femoris) by bipolar lead, using two 10 mm silver disc electrodes each, attached about 5 mm apart with electrode paste and restrained with a vinyl adhesive tape. Responses evoked by stimulation with a Nihon
Koden MSE-3R stimulator were recorded with a San-ei Sokki 1A11-A electroencephalograph.
Destruction of the internal capsule was achieved by electrical charge of the deep electrode, 40 volts DC for a period of about 1 minute. After the destruction of the internal capsule, rabbits were maintained for about 4 weeks during which changes in threshold for evoked muscular discharge were followed. The measurement of the threshold was carried out before and 24-48 hours after the internal capsule destruction and thereafter at 1 week intervals. At the end of the experiments the brain was removed and fixed in 10 per cent formalin. The exact site of destruction was determined by serial sections.
The drug was administered daily by oral route, beginning upon confirmation of elevation of the threshold of evoked muscular discharge by destruction the internal capsule. Measurement of the threshold was made immediately prior to administration of the drug.
Results
It was necessary to carry out a control experiment in consideration of the possibility that natural healing of the injured nerve tissue might occur during the 1 month period of observation, leading to decline in the threshold. In Figure 1 , data from the control experiment are exemplified. As can be seen from the electromyograms (fore-limb, FEMG; hind-limb, HEMG)
presented, the threshold of the fore-and hind-limbs by stimulation of the cerebral cortex which was 3V prior to destruction of the internal capsule became elevated to 5V on the day following destruction, to 8V one week after the destruction, and raised further to 15V in the fore-limb and 20V in the hind-limb at 4 weeks. The data concerned with threshold of evoked muscular discharge observed in the control experiment are summarized together with the threshold for causing EEG changes (increases in amplitude and frequency) , both expressed in the unit of The mean curves show that the threshold for causing EEG change increased by about 50% and the threshold of evoked muscular discharge by 130% soon after destruction of the internal capsule, and both thresholds continued to increase over the ensuing period to become elevated by 350% and 400% respectively at 4 weeks after the destruction. Figure 4 is an APO section of the brain according to the Sawyer's stereotaxic coordinates, illustrating the destroyed area (black shaded) of the internal capsule.
Following the control experiment, experiments were performed in rabbits dosed daily with CDP-choline by oral route. Figure 5 shows the data from a case in which CDP-choline was administered orally in doses of 50mg/kg p. o. The threshold in the fore-and hind-limbs of the rabbit which was 1. 6V prior to destruction of the internal capsule became elevated to 5. 6V
after the destruction. It increased further to 20V in 2 weeks of daily oral dosage of CDPcholine and and to 30V by 4 weeks of the medication. The threshold data obtained in five animals receiving 50 mg/kg p. o. of CDP-choline daily are summarized in Table 2 . In all five cases elevation of the threshold occurred following destruction of the internal capsule despite administration of CDP-choline in doses of 50 mg/kg p. o. daily. These data are graphically illustrated in Figures 6 and 7 , as in the foregoing graphs of data from the control experiment. It is evident from the graphs that the threshold was elevated in all animals with internal capsule Namely, the graph of EEG changes show that the threshold increased 50% soon after destruction of the internal capsule and found to have become raised 400% at 4 weeks (Fig. 6) . The graph illustrating changes in evoked muscular discharge
shows an elevation of the threshold by 150% following the destruction and by 600% at 4 weeks (Fig. 7) . Figure 8 shown in Figure 9 . In this example of experiment, the threshold which was 4V before destruction of the internal capsule was elevated to 12V after the destruction and to 20V 4 weeks later. In Table 3 are summarized the data obtained for threshold, expressed in voltage, as in Tables 1 and 2 . Figures 10 and 11 are graphical illustrations of the data. As can be noted from Figure 10 showing EEG changes, the threshold which increased following destruc- tion of the internal capsule was elevated further 1 week after the destruction and by 400% at 4 weeks, thus consistent with the foregoing findings. As evident from the muscular discharge data in Figure 11 , however, the animals displayed an increase by 147% in the fore-limb and by 159% in the hind-limb following destruction of the internal capsule, followed by a decline nearly to 40% over the initial level at 1 week after the destruction. The threshold became reincreased subsequently dy more than 200% at 4 weeks. Figure 12 is a histological representation of the internal capsule illustrating the destroyed region in a rabbit dosed daily with CDP-chline, 100 mg/kg/day p. o. The area of destruction extends from A4 to P1. discharges due to stimulation of the cerebral cortex and hippocampus is based on the rationale that the evoked muscular discharge due to stimulation of the cerebral cortex is known to be related to function of the pyramidal system while that incited by stimulation of the hippocampus has bearing on the extrapyramidal system, and, therefore, the effect of a drug can be demonstrated with distinction as to whether it is directed toward the pyramidal system or, otherwise, toward the extrapyramidal system. Even if the drug has proven to act upon the pyramidal system is such test, however, the patient with motor dysfunction does not necessarily benefit from administration of the drug. In view of this, we have employed the experimental procedure more closely allied to the clinical condition in which the effect was investigated in animals with destruction of the internal capsule receiving daily doses of the drug', 4) . While the functional significance of EEG changes which emerge in response to stimulation of the cerebral cortex has not been clearly elucidated, it has been shown that evoked muscular discharge in the limbs due to stimulation of the cerebral cortex has relation to the activity of the pyramidal system. It follows that the degree of functional recovery of the pyramidal system can be estimated through observation and analysis of changes in muscular discharge and threshold in the experiment on animals with destruction of the internal capsule. By experiments on animals with destroyed internal capsule in which the threshold was measured weekly over a period of 4 weeks, we have demonstrated effectiveness of such drugs as cytochrome C and CDP-choline in motor dysfunction when administered daily by intravenous route, employing the criterion that the medication was effective when an ultimate decline of the threshold to the initial level prior to destruction of the internal capsule was achieved. With cytochrome C as well as with CDPcholine, return to the initial level of threshold was achieved in a week of intravenous medication. No such decline of the threshold was attained in the present study with oral administration of CDP-choline, though the threshold showed a temporary fall to a considerable extent at 1 week after the destruction of the internal capsule, followed by a rerise over the ensuing weeks, in animals receiving 100 mg/kg of CDP-choline daily by oral route. The data heretofore obtained do not suffice for making any comment on the underlying mechanisms. Whatever the mechanisms, it cannot be said eventually from the results of the present study that the oral administration of CDP-choline in doses of 100 mg/kg p. o. was effective. Our previous report4) described that CDP-choline administered orally in doses of 50 or 100 mg/kg failed to lower the arousal reaction and evoked muscular discharge, that is, CDP-choline was devoid of the facilitatory effect in regaining consciousness and in recovering motor function when administered by oral route. The data presented in this report demonstrate that CDP-choline, when administered orally, exerts no significant effect on motor dysfunction due to destruction of the internal capsule, wihich would suggest that no long-sustained clinical benefit can be expected Supplement to J. Kansai Med. Univ. , Vol. 34, Dec. 1982
